TGF-β1 of no avail as prognostic marker in lyme disease
Background. Within the present in vivo study using the wild type mouse strains C3H/HeN and FVB/N it was intended to (1) measure TGF-β1 expression in the course of lyme disease, (2) examine the potential correlation of TGF-β1 expression with the clinical outcome of a Borrelia infection (with a focus...
Main Author: | Julia Schumann |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2014-05-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/398.pdf |
Similar Items
-
Polymorphisms of TGF-β1 and TGF-β3 in Chinese women with gestational diabetes mellitus
by: Yinglei Xu, et al.
Published: (2020-12-01) -
Cutaneous recurrence of long term pulmonary sarcoidosis - literature review and case report
by: Julia Bargieł, et al.
Published: (2023-08-01) -
Noggin inhibits TGF-β1 OR TGF-β3 induced chondrogenesis of mesenchymal stromal cells
by: L Wen, et al.
Published: (2024-05-01) -
Dysregulation of the immune response in TGF-β signalopathies
by: Marco M. Rodari, et al.
Published: (2022-12-01) -
TGF-β1-Mediated FDNCR1 Regulates Porcine Preadipocyte Differentiation via the TGF-β Signaling Pathway
by: Zhe Zhang, et al.
Published: (2020-08-01)